The capability of modern medicine to save and improve the quality of life around the globe is truly impressive, but difficulties in production and distribution is preventing access for many millions more. For instance, Insulin, which has been around for 60 years, is still unaffordable for a large majority of the global diabetic population. A technology revolution is needed to enhance global healthcare access and affordability.
Join Henry Daniell, the W. D. Miller Professor & Vice Chair of the Department of Basic and Translational Sciences at the University of Pennsylvania as he discusses how replacing injections with biopharmaceutical oral or topical delivery could eliminate the prohibitively expensive fermentation, purification, cold chain processes that have been used in pharmaceutical industry for decades. Register now to discover how plant produced biopharmaceuticals provide an all-access opportunity for worldwide healthcare.
This ACS Webinar is moderated Christa E. Müller, Head of Department in the Pharmaceutical Institute at the University of Bonn, Germany, and Editor-in-Chief, ACS Pharmacology & Translational Science and is co-produced with ACS Publications and the ACS Division of Medicinal Chemistry.
What You Will Learn
- Why current biologics are expensive and unaffordable
- New approaches in noninvasive drug delivery
- Strategies using biopharmaceuticals to improve affordability and patient compliance
Co-Producer
What an attendee said about this ACS Webinar!
This particular webinar was extremely interesting; I was not previously familiar with this drug delivery platform. I also appreciated the presenter's broader comments about the need to reduce drug costs and accelerate translation.
;void(0);){kind=link}